User contributions
From WikiPathways
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)
- 12:28, 29 January 2021 Penny (top)
- 15:12, 8 January 2021 Homo sapiens:RAS and bradykinin pathways in COVID-19 (Updated link from Angiotensin II to AGTR1 and SERPINE1 leading to the Complement and Coagulation Cascades-pathway.)
- 13:56, 10 December 2020 Homo sapiens:RAS and bradykinin pathways in COVID-19 (Added link to Complement and Coagulation cascades WP558)
- 12:37, 16 April 2020 Penny (→Links)
- 12:18, 16 April 2020 Penny (→Portals)
- 12:17, 16 April 2020 Penny (→About Me)
- 12:16, 16 April 2020 Penny (→Portals)
- 12:14, 16 April 2020 Penny (→Pathways of Interest)
- 12:10, 16 April 2020 Penny (→Portals)
- 08:34, 15 April 2020 Homo sapiens:COVID-19 adverse outcome pathway (Updated connection between ACE2 and AGT. Added link to WP4883.)
- 08:24, 15 April 2020 Homo sapiens:SARS-CoV-2 and ACE2 receptor: molecular mechanisms (Reverted to version '16:56, 6 April 2020' by <a href="/index.php/User:Penny" title="User:Penny">Penny</a>)
- 08:02, 15 April 2020 Homo sapiens:SARS-CoV-2 and ACE2 receptor: molecular mechanisms (Updated connection between ACE2 and AGT)
- 08:48, 8 April 2020 Homo sapiens:COVID-19 adverse outcome pathway (Added date of access for CTD)
- 08:47, 8 April 2020 Homo sapiens:COVID-19 adverse outcome pathway (Added reference to origin of genes)
- 08:39, 8 April 2020 Homo sapiens:COVID-19 adverse outcome pathway (Updates in line with AOP:320 and analysis of COVID-19 genes)
- 07:05, 8 April 2020 Homo sapiens:Lung fibrosis (Updated the Legend of the AOP description in line with the current AOP:173)
- 13:23, 7 April 2020 N Homo sapiens:COVID-19 adverse outcome pathway (New pathway)
- 13:14, 23 November 2017 Mus musculus:Lung fibrosis (Added reference to publication doi: 10.1093/toxsci/kfx252)
- 13:13, 23 November 2017 Homo sapiens:Lung fibrosis (Added reference to publication doi: 10.1093/toxsci/kfx252)
- 12:06, 23 May 2017 Homo sapiens:Lung fibrosis (Updated links - SERPINA1 to Chemokine signaling; TGFA to SMAD7)
(Latest | Earliest) View (newer 20) (older 20) (20 | 50 | 100 | 250 | 500)